News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MURPHY ANDREW J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2023 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Gifted 1,326 shares
@ $0 |
|
| 12/20/2022 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 4,129 shares
@ $0
Granted 15,238 options to buy
@ $726.53, valued at
$11.1M
|
|
| 12/13/2022 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 492 shares
@ $753.28, valued at
$370.6k
|
|
| 11/16/2022 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Gifted 1,360 shares
@ $0
Paid exercise price by delivering 6,280 shares
@ $746, valued at
$4.7M
Sold 109 shares
@ $718.6, valued at
$78.3k
Sold 336 shares
@ $719.62, valued at
$241.8k
Sold 3 shares
@ $720.26, valued at
$2.2k
Sold 297 shares
@ $721.74, valued at
$214.4k
Sold 272 shares
@ $722.36, valued at
$196.5k
Sold 57 shares
@ $723.19, valued at
$41.2k
Sold 222 shares
@ $726.48, valued at
$161.3k
Sold 333 shares
@ $727.17, valued at
$242.1k
Sold 361 shares
@ $728.44, valued at
$263k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 6,460 shares
@ $626.79, valued at
$4M
Sold 99 shares
@ $622.09, valued at
$61.6k
Sold 50 shares
@ $625.9, valued at
$31.3k
Sold 421 shares
@ $626.51, valued at
$263.8k
Sold 630 shares
@ $627.49, valued at
$395.3k
Sold 520 shares
@ $628.62, valued at
$326.9k
Sold 533 shares
@ $629.35, valued at
$335.4k
Sold 434 shares
@ $630.41, valued at
$273.6k
Sold 185 shares
@ $631.67, valued at
$116.9k
Sold 289 shares
@ $632.71, valued at
$182.9k
Sold 220 shares
@ $633.54, valued at
$139.4k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Gifted 1,645 shares
@ $0
Paid exercise price by delivering 9,412 shares
@ $641.5, valued at
$6M
Sold 465 shares
@ $642.76, valued at
$298.9k
Sold 924 shares
@ $643.42, valued at
$594.5k
Sold 1,106 shares
@ $644.71, valued at
$713k
Sold 1,640 shares
@ $645.41, valued at
$1.1M
Sold 557 shares
@ $646.52, valued at
$360.1k
Sold 844 shares
@ $647.39, valued at
$546.4k
Sold 86 shares
@ $648.2, valued at
$55.7k
Sold 5 shares
@ $649.26, valued at
$3.2k
Sold 296 shares
@ $651.42, valued at
$192.8k
|
|
| 12/11/2020 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,285 shares
@ $0
Granted 1,929 shares
@ $0
Granted 25,000 options to buy
@ $492, valued at
$12.3M
|
|
| 11/18/2020 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 7,108 shares
@ $561.39, valued at
$4M
Sold 743 shares
@ $536.68, valued at
$398.8k
Sold 229 shares
@ $537.38, valued at
$123.1k
Sold 591 shares
@ $538.37, valued at
$318.2k
Sold 42 shares
@ $539.87, valued at
$22.7k
Sold 1,442 shares
@ $540.49, valued at
$779.4k
Sold 812 shares
@ $541.42, valued at
$439.6k
Sold 294 shares
@ $542.37, valued at
$159.5k
Sold 467 shares
@ $543.65, valued at
$253.9k
Sold 68 shares
@ $544.01, valued at
$37k
Sold 171 shares
@ $545.47, valued at
$93.3k
|
|
| 10/23/2020 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,264 options to buy
@ $30.63, valued at
$100k
Exercised 1,921 options to buy
@ $52.03, valued at
$99.9k
|
|
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2020 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 200 shares
@ $336.78, valued at
$67.4k
Sold 270 shares
@ $337.46, valued at
$91.1k
Sold 712 shares
@ $338.54, valued at
$241k
Sold 567 shares
@ $339.37, valued at
$192.4k
Sold 1,355 shares
@ $340.56, valued at
$461.5k
Sold 3,283 shares
@ $341.58, valued at
$1.1M
Sold 1,399 shares
@ $342.44, valued at
$479.1k
Sold 214 shares
@ $343.02, valued at
$73.4k
|
|
| 12/13/2019 |
4
| MURPHY ANDREW J (EVP Research) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 2,625 shares
@ $0
Granted 10,000 shares
@ $0
Granted 24,500 options to buy
@ $372.46, valued at
$9.1M
|
|
| 12/13/2019 |
3
| MURPHY ANDREW J (EVP Research) has filed a Form 3 on REGENERON PHARMACEUTICALS, INC. |
|
|